Volume | 502,451 |
|
|||||
News | (2) | ||||||
Day High | 2.06 | Low High |
|||||
Day Low | 1.80 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.06 | 1.80 | 2.06 | 1.86 | 1.98 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,447 | 502,451 | $ 1.92 | $ 966,511 | - | 1.80 - 63.90 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:36:47 | 1 | $ 1.81 | USD |
MyMD Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.89M | 2.09M | - | 0 | -8.22M | -3.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
MyMD Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.00 | 2.0798 | 1.80 | 1.98 | 233,467 | -0.21 | -10.50% |
1 Month | 3.35 | 3.3669 | 1.80 | 2.12 | 90,752 | -1.56 | -46.57% |
3 Months | 3.24 | 3.5999 | 1.80 | 2.57 | 255,612 | -1.45 | -44.75% |
6 Months | 8.67 | 10.665 | 1.80 | 6.09 | 875,167 | -6.88 | -79.35% |
1 Year | 54.90 | 63.90 | 1.80 | 15.88 | 777,880 | -53.11 | -96.74% |
3 Years | 133.20 | 298.50 | 1.80 | 51.60 | 419,331 | -131.41 | -98.66% |
5 Years | 162.90 | 298.50 | 1.80 | 57.16 | 429,706 | -161.11 | -98.90% |
MyMD Pharmaceuticals Description
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |